Nikhil Prasad Fact checked by:Thailand Medical News Team Aug 29, 2026 52 minutes ago
Metabolic problems involving blood sugar, diabetes, and abdominal fat may provide stronger warning signals for pancreatic cancer risk than individual foods, according to an umbrella review.
Abnormal blood glucose, diabetes, metabolic syndrome, and abdominal obesity emerged as important metabolic
signals associated with pancreatic cancer risk
Researchers from the Division of Population Health, Health Services Research and Primary Care, School of Health Sciences, Faculty of Biology, Medicine and Health at The University of Manchester, United Kingdom, evaluated 17 systematic reviews, meta-analyses, and umbrella reviews published from 2021 to 2026.
Blood Sugar Emerges as a Major Signal
A key finding highlighted in this
Thailand Medical News report was the strong association involving impaired glucose regulation. Hyperglycemia showed the strongest association among individual metabolic syndrome components, with a relative risk of 1.55, indicating approximately 55% higher relative risk.
Diabetes mellitus was also consistently associated with pancreatic cancer. Cohort evidence produced a hazard ratio of 2.39, while case-control studies produced an odds ratio of 2.30.
The relationship was strongest during the first two years after diabetes diagnosis. Case-control studies showed an odds ratio of 3.27, while cohort studies reported a hazard ratio of 4.29. This requires caution because pancreatic cancer itself can disrupt glucose metabolism before diagnosis. New-onset diabetes may therefore be an early sign of an undetected tumor rather than solely a cause of increased cancer risk.
Prediabetes was associated with a 40% higher risk, although the evidence was classified as limited or suggestive.
Abdominal Fat Shows a Clear Association
Fat distribution also mattered. Higher waist circumference was associated with a 33% higher relative risk of pancreatic cancer, while higher waist-to-hip ratio was associated with a 42% increase.
Metabolic syndrome was associated with a 34% higher relative risk. General obesity showed weaker and less consistent evidence, suggesting that abdominal adiposity and broader metabolic abnormalities may provide more meaningful information than body mass index alone.
Dietary Findings Are Less Certain
Diet produced less consistent findings. Red meat, white meat, fructose, and ultra-processed foods were classified as having limited or suggestive evidence.
Higher fructose intake was associated with a 22% increased relative risk, while people in the highest category of ultra-processed food consumption had a 49% higher risk than those in the lowest category. However, pancreatic cancer-specific evidence for ultra-processed foods was limited.
Protein intake, processed meat, artificially sweetened beverages, sugar-sweetened beverages, non-sugar-sweetened beverages, and dietary glycemic index/load did not provide consistent evidence for firm conclusions. No exposure examined achieved the highe
st “convincing” evidence classification.
Conclusions
The review suggests that pancreatic cancer risk is more consistently associated with systemic metabolic dysfunction—particularly abnormal glucose regulation, diabetes, metabolic syndrome, and abdominal obesity—than with individual dietary exposures. However, these associations do not prove cause and effect. Future prospective studies using repeated metabolic measurements, biomarkers, genetic approaches, and mechanistic research will be essential for determining which metabolic abnormalities actually contribute to cancer development and which may represent early consequences of an undiagnosed tumor.
The study findings were published in the peer reviewed International Journal of Molecular Sciences.
https://www.mdpi.com/1422-0067/27/17/7707
Read Also:
https://www.thailandmedical.news/articles/cancer
https://www.thailandmedical.news/articles/diabetes 
Share
Tweet
Share
